Indergand S, Graf J
Institute for Infectious Diseases, University of Berne, CH-3010 Berne, Switzerland.
Appl Environ Microbiol. 2000 Nov;66(11):4735-41. doi: 10.1128/AEM.66.11.4735-4741.2000.
Hirudo medicinalis, the medicinal leech, usually carries in its digestive tract a pure culture of Aeromonas veronii bv. sobria. Such specificity is unusual for digestive tracts that are normally colonized by a complex microbial consortium. Important questions for the symbiotic interaction and for the medical application after microvascular surgery are whether other bacteria can proliferate or at least persist in the digestive tract of H. medicinalis and what factors contribute to the reported specificity. Using a colonization assay, we were able to compare experimentally the ability of clinical isolates and of a symbiotic strain to colonize H. medicinalis. The symbiotic A. veronii bv. sobria strain proliferated well and persisted for at least 7 days inside the digestive tract. In contrast, the proliferation of Pseudomonas aeruginosa and Staphylococcus aureus was inhibited inside the animal compared to growth in the in vitro control, indicating that the ingested blood was modified within the digestive tract. However, both strains were able to persist in the digestive tract for at least 7 days. For an Escherichia coli strain, the viable counts decreased approximately 1, 000-fold within 42 h. The decrease of viable E. coli could be prevented by interfering with the activation of the membrane-attack complex of the complement system that is present in blood. This suggests that the membrane-attack complex remained active inside H. medicinalis and prevented the proliferation of sensitive bacteria. Thus, antimicrobial properties of the ingested vertebrate blood contribute to the specificity of the A. veronii-H. medicinalis symbiosis, in addition to modifications of the blood inside the digestive tract of H. medicinalis.
药用蚂蟥(Hirudo medicinalis)的消化道中通常携带着维氏气单胞菌温和生物变种(Aeromonas veronii bv. sobria)的纯培养物。对于通常由复杂微生物群落定殖的消化道而言,这种特异性并不常见。对于共生相互作用以及微血管手术后的医学应用来说,重要的问题是其他细菌是否能够在药用蚂蟥的消化道中增殖或至少持续存在,以及哪些因素导致了所报道的特异性。通过定殖试验,我们能够通过实验比较临床分离株和共生菌株定殖药用蚂蟥的能力。共生的维氏气单胞菌温和生物变种菌株增殖良好,并在消化道内持续存在至少7天。相比之下,与体外对照中的生长情况相比,铜绿假单胞菌和金黄色葡萄球菌在动物体内的增殖受到抑制,这表明摄入的血液在消化道内发生了改变。然而,这两种菌株都能够在消化道内持续存在至少7天。对于一株大肠杆菌,其活菌数在42小时内下降了约1000倍。通过干扰血液中存在的补体系统膜攻击复合物的激活,可以防止大肠杆菌活菌数的下降。这表明膜攻击复合物在药用蚂蟥体内仍然具有活性,并阻止了敏感细菌的增殖。因此,除了药用蚂蟥消化道内血液的改变之外,摄入的脊椎动物血液的抗菌特性也有助于维氏气单胞菌 - 药用蚂蟥共生关系的特异性。